Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avenir Wellness Solutions Inc AVRW

Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production... see more

Recent & Breaking News (OTCQB:AVRW)

CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference

GlobeNewswire January 9, 2019

CURE Pharmaceutical Secures U.S. DEA Approval to Manufacture Cannabinoid-based Pharmaceuticals

GlobeNewswire November 26, 2018

CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer

GlobeNewswire November 14, 2018

Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical

GlobeNewswire November 1, 2018

CURE Pharmaceutical to Present at CannX 2018 International Medical Cannabis Conference

GlobeNewswire October 10, 2018

CURE Pharmaceutical to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House

GlobeNewswire September 28, 2018

CURE Pharmaceutical Secures Patent for Oral Thin Film Containing Bioactive Cannabinoid Molecules

GlobeNewswire September 25, 2018

CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement

GlobeNewswire September 5, 2018

Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.

GlobeNewswire July 11, 2018

CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference

GlobeNewswire June 5, 2018

CURE Pharmaceutical to Showcase Company Growth at the 8th LD Micro Invitational

GlobeNewswire May 23, 2018

CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production

GlobeNewswire May 1, 2018

CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules

GlobeNewswire April 4, 2018

CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year

GlobeNewswire April 3, 2018

UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies

GlobeNewswire March 23, 2018

CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies

GlobeNewswire March 23, 2018

CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ

GlobeNewswire March 23, 2018

Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing

GlobeNewswire March 14, 2018

CURE Pharmaceutical Adds Healthcare Luminary To Advisory Board, Secures $1 Million Investment as a Bridge to Uplisting

GlobeNewswire February 21, 2018

CURE Pharmaceutical Adds New VP of Strategy and Business Development

Business Wire January 25, 2018